Clarius Group LLC boosted its holdings in Denali Therapeutics Inc. ( NASDAQ:DNLI – Get Rating ) by 11.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 290,330 shares of the company's stock after acquiring an additional 29,726 shares during the period. Denali Therapeutics accounts for about 0.6% of Clarius Group LLC's portfolio, making the stock its 25th largest holding. Clarius Group LLC owned approximately 0.21% of Denali Therapeutics worth $6,689,000 at the end of the most recent quarter.

https://www.dailypolitical.com/2023/06/26/denali-therapeutics-inc-nasdaqdnli-shares-purchased-by-clarius-group-llc.html

#dailypolitical